Clinical Trial Update: Immediate Corticosteroid Therapy and Rituximab to Prevent Generalization in Ocular Myasthenia: a PROBE Multicenter Open-label Randomized Controlled Trial. [Phase 3]

View source ↗

Summary

Phase 3 PROBE multicenter open-label randomized trial evaluating immediate corticosteroid therapy combined with rituximab to prevent generalization from ocular …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Myasthenia Gravis

Drugs mentioned

• Corticosteroid therapy (corticosteroid)
• Rituximab (rituximab)

Snippet

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild | Conditions: Ocular Myasthenia Gravis | Phase 3 | Status: RECRUITING